Publications by authors named "Steven Hull"

Claim this Profile
A
A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
Russell P Rosenberg, Steven G Hull, D Alan Lankford, David W Mayleben, David J Seiden

J Clin Sleep Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
Sandy A Furey, Steven G Hull, Mark T Leibowitz, Shyamalie Jayawardena, Thomas Roth

J Clin Sleep Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder.
John Harsh, Ronghua Yang, Steven G Hull

Curr Med Res Opin· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.
John J Treanor, Brandon Essink, Steven Hull, Steven Reed, Ruvim Izikson

Vaccine· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
Jed E Black, Steven G Hull, Jane Tiller, Ronghua Yang, John R Harsh

J Clin Sleep Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.
Russell Rosenberg, David J Seiden, Steven G Hull, Milton Erman, Howard Schwartz

Sleep· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
Martin Scharf, Roberta Rogowski, Steven Hull, Martin Cohn, David Mayleben

J Clin Psychiatry· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
Thomas Roth, Steven G Hull, D Alan Lankford, Russell Rosenberg, Martin B Scharf

Sleep· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.
Thomas Roth, Roberta Rogowski, Steven Hull, Howard Schwartz, Gail Koshorek

Sleep· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term nightly treatment with indiplon in adults with primary insomnia: results of a double-blind, placebo-controlled, 3-month study.
Martin B Scharf, Jed Black, Steven Hull, Rick Landin, Robert Farber

Sleep· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis